In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration (Q44566017)
Jump to navigation
Jump to search
scientific article published on 27 August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration |
scientific article published on 27 August 2003 |
Statements
1 reference
In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration (English)
1 reference
Kuss H
1 reference
Hoefgen N
1 reference
Johanssen S
1 reference
Kronbach T
1 reference
Rundfeldt C
1 reference
27 August 2003
1 reference
1 reference
307
1 reference
1
1 reference
373-385
1 reference
Identifiers
1 reference
1 reference